Verification evidence is still being completed.
PDF / print export
ArcticZymes Technologies
Tromso, Norway
- Verified lead
- Michael B. Akoh
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Cold-adapted Enzymes
- Review cycle
- May 2026
- Full address
- Sykehusvegen 23, 9019 Tromsø, Norway
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ArcticZymes leadership page confirming Michael B. Akoh as CEO.
- Editorial note
- ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B. Akoh as CEO.
Cold-adapted Enzymes
ISO 13485, GMP Ready
ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B. Akoh as CEO.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Tromso, Norway
ArcticZymes Technologies
Cold-adapted Enzymes · Global Manufacturing
ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B.
- Lead
- Michael B. Akoh (verified ↗)
- Address
- Sykehusvegen 23, 9019 Tromsø, Norway (source ↗)
- Compliance
- ISO 13485 · GMP Ready
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global Manufacturing
- Capabilities
- Nuclease Synthesis · Polymerase Optimization · Molecular Research Tools
- Founded
- 1996
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Michael B. Akoh
Chief Executive Officer
Full addressSykehusvegen 23, 9019 Tromsø, Norway
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official ArcticZymes customer-service page naming Sykehusvegen 23, Tromsø as the company address.
Open sourceGlobal Manufacturing
Tromso, Norway. Cold-adapted Enzymes. Review completed on 14 Mar 2026.
Norwegian Health Authorities
ISO 13485, GMP Ready
Cold-adapted Enzymes
ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B. Akoh as CEO.
Editorial note
ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B. Akoh as CEO.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Nuclease Synthesis
Polymerase Optimization
Molecular Research Tools
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Industrial Fermentation Skids
Assay Automation
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is ArcticZymes Technologies located?
- ArcticZymes Technologies operates from Sykehusvegen 23, 9019 Tromsø, Norway, Tromso, Norway.
- Who runs ArcticZymes Technologies?
- ArcticZymes Technologies is led by Michael B. Akoh, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does ArcticZymes Technologies hold?
- ArcticZymes Technologies is documented under ISO 13485, GMP Ready.
- What does ArcticZymes Technologies do?
- ArcticZymes returns as a strong verified Nordic profile through its live leadership page and February 2026 results commentary naming Michael B. Core capabilities: Nuclease Synthesis, Polymerase Optimization, Molecular Research Tools.
Editorial context
Related technical briefs
Briefs that name Tromso as a covered market or city.